$WAT
WATERS CORP /DE/

2013 Q1 Form 10-Q Financial Statement

#000119312513198015 Filed on May 03, 2013

View on sec.gov

Income Statement

Concept 2013 Q1 2012 Q1
Revenue $430.3M $420.5M
YoY Change 2.35%
Cost Of Revenue $174.6M $167.3M
YoY Change 4.35%
Gross Profit $255.8M $253.2M
YoY Change 1.03%
Gross Profit Margin 59.43% 60.21%
Selling, General & Admin $118.7M $117.1M
YoY Change 1.32%
% of Gross Profit 46.39% 46.26%
Research & Development $25.31M $23.35M
YoY Change 8.42%
% of Gross Profit 9.9% 9.22%
Depreciation & Amortization $8.487M $7.763M
YoY Change 9.33%
% of Gross Profit 3.32% 3.07%
Operating Expenses $144.0M $140.5M
YoY Change 2.5%
Operating Profit $109.4M $110.2M
YoY Change -0.74%
Interest Expense $7.185M $6.491M
YoY Change 10.69%
% of Operating Profit 6.57% 5.89%
Other Income/Expense, Net
YoY Change
Pretax Income $103.4M $104.5M
YoY Change -1.04%
Income Tax -$17.65M $15.83M
% Of Pretax Income -17.07% 15.15%
Net Earnings $121.1M $88.70M
YoY Change 36.53%
Net Earnings / Revenue 28.14% 21.1%
Basic Earnings Per Share
Diluted Earnings Per Share $1.389M $982.3K
COMMON SHARES
Basic Shares Outstanding 86.05M shares 88.99M shares
Diluted Shares Outstanding 87.22M shares 90.27M shares

Balance Sheet

Concept 2013 Q1 2012 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.590B $1.354B
YoY Change 17.46%
Cash & Equivalents $472.0M $427.2M
Short-Term Investments $1.118B $926.4M
Other Short-Term Assets $84.53M $82.82M
YoY Change 2.07%
Inventory $235.9M $233.4M
Prepaid Expenses
Receivables $377.4M $353.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $2.288B $2.023B
YoY Change 13.06%
LONG-TERM ASSETS
Property, Plant & Equipment $282.7M $239.0M
YoY Change 18.31%
Goodwill $315.1M $309.1M
YoY Change 1.96%
Intangibles $215.0M $205.4M
YoY Change 4.69%
Long-Term Investments
YoY Change
Other Assets $106.8M $62.54M
YoY Change 70.74%
Total Long-Term Assets $919.6M $815.9M
YoY Change 12.71%
TOTAL ASSETS
Total Short-Term Assets $2.288B $2.023B
Total Long-Term Assets $919.6M $815.9M
Total Assets $3.207B $2.839B
YoY Change 12.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $59.79M $61.47M
YoY Change -2.73%
Accrued Expenses $37.00M $40.00M
YoY Change -7.5%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $133.2M $323.6M
YoY Change -58.84%
Total Short-Term Liabilities $476.9M $648.3M
YoY Change -26.44%
LONG-TERM LIABILITIES
Long-Term Debt $1.100B $700.0M
YoY Change 57.14%
Other Long-Term Liabilities $29.67M $29.45M
YoY Change 0.76%
Total Long-Term Liabilities $1.254B $903.6M
YoY Change 38.77%
TOTAL LIABILITIES
Total Short-Term Liabilities $476.9M $648.3M
Total Long-Term Liabilities $1.254B $903.6M
Total Liabilities $1.731B $1.552B
YoY Change 11.53%
SHAREHOLDERS EQUITY
Retained Earnings $3.634B $3.140B
YoY Change 15.73%
Common Stock $1.175B $1.119B
YoY Change 5.01%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.278B $2.948B
YoY Change 11.16%
Treasury Stock Shares 68.41M shares 64.53M shares
Shareholders Equity $1.477B $1.288B
YoY Change
Total Liabilities & Shareholders Equity $3.207B $2.839B
YoY Change 12.96%

Cashflow Statement

Concept 2013 Q1 2012 Q1
OPERATING ACTIVITIES
Net Income $121.1M $88.70M
YoY Change 36.53%
Depreciation, Depletion And Amortization $8.487M $7.763M
YoY Change 9.33%
Cash From Operating Activities $127.8M $111.2M
YoY Change 14.93%
INVESTING ACTIVITIES
Capital Expenditures -$30.60M -$15.50M
YoY Change 97.42%
Acquisitions $0.00 $18.41M
YoY Change -100.0%
Other Investing Activities -$59.80M -$47.40M
YoY Change 26.16%
Cash From Investing Activities -$90.45M -$62.95M
YoY Change 43.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $101.4M $68.08M
YoY Change 48.9%
Debt Paid & Issued, Net $10.18M $18.04M
YoY Change -43.57%
Cash From Financing Activities -$34.58M -$12.00M
YoY Change 188.3%
NET CHANGE
Cash From Operating Activities $127.8M $111.2M
Cash From Investing Activities -$90.45M -$62.95M
Cash From Financing Activities -$34.58M -$12.00M
Net Change In Cash $2.764M $36.25M
YoY Change -92.37%
FREE CASH FLOW
Cash From Operating Activities $127.8M $111.2M
Capital Expenditures -$30.60M -$15.50M
Free Cash Flow $158.4M $126.7M
YoY Change 25.02%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q1 dei Entity Registrant Name
EntityRegistrantName
WATERS CORP /DE/
CY2013Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001000697
CY2013Q1 dei Document Type
DocumentType
10-Q
CY2013Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2013Q1 dei Document Period End Date
DocumentPeriodEndDate
2013-03-30
CY2013Q1 dei Amendment Flag
AmendmentFlag
false
CY2013Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013Q1 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2013Q1 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2012Q2 dei Entity Public Float
EntityPublicFloat
6966563351 USD
CY2013Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
85687806 shares
CY2013Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
472048000 USD
CY2013Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
377412000 USD
CY2013Q1 us-gaap Inventory Net
InventoryNet
235883000 USD
CY2013Q1 us-gaap Other Assets Current
OtherAssetsCurrent
84532000 USD
CY2013Q1 us-gaap Assets Current
AssetsCurrent
2287681000 USD
CY2013Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282716000 USD
CY2013Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
214993000 USD
CY2013Q1 us-gaap Goodwill
Goodwill
315145000 USD
CY2013Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
106782000 USD
CY2013Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12656000 USD
CY2012Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12353000 USD
CY2013Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
73656000 USD
CY2012Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
90116000 USD
CY2013Q1 us-gaap Liabilities Current
LiabilitiesCurrent
476866000 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
504242000 USD
CY2013Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1100000000 USD
CY2013Q1 us-gaap Assets
Assets
3207317000 USD
CY2013Q1 us-gaap Debt Current
DebtCurrent
133232000 USD
CY2012Q4 us-gaap Debt Current
DebtCurrent
132781000 USD
CY2013Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
59789000 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
54724000 USD
CY2013Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
24375000 USD
CY2012Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
31910000 USD
CY2013Q1 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
145338000 USD
CY2012Q4 us-gaap Deferred Revenue And Credits Current
DeferredRevenueAndCreditsCurrent
121470000 USD
CY2013Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
27820000 USD
CY2012Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
60888000 USD
CY2012Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1045000000 USD
CY2013Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
101725000 USD
CY2012Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
101225000 USD
CY2013Q1 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
22556000 USD
CY2012Q4 us-gaap Accrued Income Taxes Noncurrent
AccruedIncomeTaxesNoncurrent
24772000 USD
CY2013Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
29670000 USD
CY2012Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
25554000 USD
CY2013Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1253951000 USD
CY2012Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1196551000 USD
CY2013Q1 us-gaap Liabilities
Liabilities
1730817000 USD
CY2012Q4 us-gaap Liabilities
Liabilities
1700793000 USD
CY2013Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q1 us-gaap Common Stock Value
CommonStockValue
1541000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
1537000 USD
CY2013Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1173227000 USD
CY2012Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1155504000 USD
CY2013Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3633949000 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3512890000 USD
CY2013Q1 us-gaap Treasury Stock Value
TreasuryStockValue
3277546000 USD
CY2012Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3176179000 USD
CY2013Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-54671000 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-26395000 USD
CY2013Q1 us-gaap Stockholders Equity
StockholdersEquity
1476500000 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
1467357000 USD
CY2013Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3207317000 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3168150000 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
481035000 USD
CY2012Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
404556000 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
229565000 USD
CY2012Q4 us-gaap Other Assets Current
OtherAssetsCurrent
84580000 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2257726000 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
273279000 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
220145000 USD
CY2012Q4 us-gaap Goodwill
Goodwill
316834000 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
100166000 USD
CY2012Q4 us-gaap Assets
Assets
3168150000 USD
CY2013Q1 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
6593000 USD
CY2013Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2013Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2013Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2013Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2013Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
154065000 shares
CY2013Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
85659000 shares
CY2013Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
68406000 shares
CY2012Q4 wat Allowances For Doubtful Accounts And Sales Returns
AllowancesForDoubtfulAccountsAndSalesReturns
8240000 USD
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2012Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
153696000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86390000 shares
CY2012Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
67306000 shares
CY2013Q1 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1590000000 USD
CY2012Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
1539000000 USD
CY2013Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
121059000 USD
CY2013Q1 us-gaap Gross Profit
GrossProfit
255770000 USD
CY2013Q1 us-gaap Cost Of Services
CostOfServices
60816000 USD
CY2013Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
25312000 USD
CY2013Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
113752000 USD
CY2013Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
1187000 USD
CY2013Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
174568000 USD
CY2013Q1 us-gaap Sales Revenue Net
SalesRevenueNet
430338000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
103407000 USD
CY2013Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
136624000 USD
CY2013Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
118660000 USD
CY2013Q1 us-gaap Interest Expense
InterestExpense
7185000 USD
CY2013Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
109405000 USD
CY2013Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
293714000 USD
CY2013Q1 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2393000 USD
CY2013Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-17652000 USD
CY2012Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23347000 USD
CY2012Q1 us-gaap Cost Of Goods Sold
CostOfGoodsSold
109712000 USD
CY2013Q1 us-gaap Inventory Write Down
InventoryWriteDown
1340000 USD
CY2013Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7431000 USD
CY2013Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-991000 USD
CY2013Q1 us-gaap Depreciation
Depreciation
8487000 USD
CY2013Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
9775000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16499000 USD
CY2012Q1 us-gaap Sales Revenue Services Net
SalesRevenueServicesNet
133951000 USD
CY2012Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
117119000 USD
CY2012Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
167290000 USD
CY2012Q1 us-gaap Gross Profit
GrossProfit
253168000 USD
CY2012Q1 us-gaap Interest Expense
InterestExpense
6491000 USD
CY2012Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
769000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
104495000 USD
CY2012Q1 us-gaap Sales Revenue Net
SalesRevenueNet
420458000 USD
CY2012Q1 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
88666000 USD
CY2012Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
15829000 USD
CY2012Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
286507000 USD
CY2012Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
110217000 USD
CY2012Q1 us-gaap Cost Of Services
CostOfServices
57578000 USD
CY2012Q1 wat Purchased Intangibles Amortization
PurchasedIntangiblesAmortization
2485000 USD
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.41
CY2013Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
1.39
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.98
CY2012Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
1.00
CY2012Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
88992000 shares
CY2012Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
90269000 shares
CY2013Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
86049000 shares
CY2013Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
87215000 shares
CY2013Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.171 pure
CY2012Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.151 pure
CY2012Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
17227000 USD
CY2013Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
-28713000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-15000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax
-338000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-43000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-630000 USD
CY2013Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
282000 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Tax
OtherComprehensiveIncomeDefinedBenefitPlansTax
-2239000 USD
CY2013Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
480000 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPeriodIncreaseDecrease
-3478000 USD
CY2013Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
-28276000 USD
CY2012Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Period Increase Decrease
OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecrease
13119000 USD
CY2013Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
92783000 USD
CY2012Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
101785000 USD
CY2013Q1 wat Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax
-58000 USD
CY2012Q1 us-gaap Other Comprehensive Income Reclassification Adjustment For Sale Of Securities Included In Net Income Before Tax
OtherComprehensiveIncomeReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeBeforeTax
-968000 USD
CY2013Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-58000 USD
CY2012Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-968000 USD
CY2013Q1 us-gaap Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Periodic Benefit Cost Before Tax
OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCostBeforeTax
762000 USD
CY2012Q1 us-gaap Other Comprehensive Income Reclassification Of Defined Benefit Plans Net Gain Loss Recognized In Net Periodic Benefit Cost Before Tax
OtherComprehensiveIncomeReclassificationOfDefinedBenefitPlansNetGainLossRecognizedInNetPeriodicBenefitCostBeforeTax
321000 USD
CY2012Q1 wat Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentBeforeReclassificationAdjustmentsAndTax
-6038000 USD
CY2012Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
-5717000 USD
CY2013Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Before Tax Period Increase Decrease
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPeriodIncreaseDecrease
762000 USD
CY2013Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
463000 USD
CY2013Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
12840000 USD
CY2013Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
506000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6181000 USD
CY2013Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-45340000 USD
CY2013Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1777000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
127798000 USD
CY2013Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
30637000 USD
CY2013Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
767541000 USD
CY2013Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
707725000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-90453000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
65632000 USD
CY2013Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
10181000 USD
CY2013Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7478000 USD
CY2013Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
101367000 USD
CY2013Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
3163000 USD
CY2013Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-34581000 USD
CY2013Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-11751000 USD
CY2013Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-8987000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-11995000 USD
CY2012Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
6947000 USD
CY2012Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
43196000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
50094000 USD
CY2012Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
18042000 USD
CY2012Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
14554000 USD
CY2012Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
68079000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-62954000 USD
CY2012Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
491322000 USD
CY2012Q1 us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
15534000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-21306000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-304000 USD
CY2012Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
111198000 USD
CY2012Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-16012000 USD
CY2012Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
18057000 USD
CY2012Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1333000 USD
CY2012Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-1773000 USD
CY2012Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
536000 USD
CY2012Q1 us-gaap Inventory Write Down
InventoryWriteDown
3449000 USD
CY2012Q1 us-gaap Share Based Compensation
ShareBasedCompensation
7267000 USD
CY2012Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4830000 USD
CY2012Q1 us-gaap Depreciation
Depreciation
7763000 USD
CY2012Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6806000 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
383990000 USD
CY2013Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
26825000 USD
CY2012Q1 us-gaap Increase Decrease In Deferred Revenue And Customer Advances And Deposits
IncreaseDecreaseInDeferredRevenueAndCustomerAdvancesAndDeposits
24756000 USD
CY2012Q1 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
462316000 USD
CY2012Q1 us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
5503000 USD
CY2013Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 USD
CY2012Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
427186000 USD
CY2012Q1 us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
18414000 USD
CY2013Q1 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-694000 USD
CY2012Q1 us-gaap Payments For Proceeds From Hedge Financing Activities
PaymentsForProceedsFromHedgeFinancingActivities
-3975000 USD
CY2013Q1 us-gaap Nature Of Operations
NatureOfOperations
<p style='margin-top:0pt; margin-bottom:0pt'><font style="font-family:Times New Roman;font-size:10pt;margin-left:0px;">Waters Corporation (&#8220;Waters</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; or the &#8220;Company&#8221;) is</font><font style="font-family:Times New Roman;font-size:10pt;"> an analytical instrument manufacturer</font><font style="font-family:Times New Roman;font-size:10pt;"> that</font><font style="font-family:Times New Roman;font-size:10pt;"> primarily designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography (&#8220;HPLC&#8221;), ultra performance liquid chromatography (&#8220;UPLC</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221; and together with HPLC, referred to as &#8220;LC&#8221;) and mass spectrometry (&#8220;MS&#8221;) </font><font style="font-family:Times New Roman;font-size:10pt;">technology </font><font style="font-family:Times New Roman;font-size:10pt;">systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. These systems are complementary products that </font><font style="font-family:Times New Roman;font-size:10pt;">are frequently employed </font><font style="font-family:Times New Roman;font-size:10pt;">together</font><font style="font-family:Times New Roman;font-size:10pt;"> (&#8220;LC-MS&#8221;)</font><font style="font-family:Times New Roman;font-size:10pt;"> and </font><font style="font-family:Times New Roman;font-size:10pt;">sold as integrated instrument systems using a common software platform and are used along with other </font><font style="font-family:Times New Roman;font-size:10pt;">analytical instruments. LC is a standard technique and is utilized in a broad range of industries to detect, identify, monitor and measure the chemical, physical and biological composition of materials, and to purify a full range of compounds. MS instruments are used in drug discovery and development, including clinical trial testing, the analysis of proteins in disease process</font><font style="font-family:Times New Roman;font-size:10pt;">es (known as &#8220;proteomics&#8221;), nutritional</font><font style="font-family:Times New Roman;font-size:10pt;"> safety analysis and environmental testing. LC</font><font style="font-family:Times New Roman;font-size:10pt;">-MS</font><font style="font-family:Times New Roman;font-size:10pt;"> instruments </font><font style="font-family:Times New Roman;font-size:10pt;">combine </font><font style="font-family:Times New Roman;font-size:10pt;">a liquid phase sample introduction and separation system with mass spectrometric compound identification and quantification. Through its TA Division (&#8220;TA</font><font style="font-family:Times New Roman;font-size:10pt;">&#174;</font><font style="font-family:Times New Roman;font-size:10pt;">&#8221;), the Company primarily designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments, which are used in predicting the suitability of fine chemicals, polymers and viscous liquids for various industrial, consumer goods and healthcare products, as well as for life science research. The Company is also a developer and supplier of software-based products that interface with the Company's instruments and are typically purchased by customers as part of the instrument system.</font></p>
CY2013Q1 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
167160000 USD
CY2013Q1 us-gaap Short Term Investments
ShortTermInvestments
1117806000 USD
CY2013Q1 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
26541000 USD
CY2013Q1 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
136000 USD
CY2013Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1311643000 USD
CY2013Q1 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
226000 USD
CY2013Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
226000 USD
CY2012Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
146232000 USD
CY2012Q4 us-gaap Short Term Investments
ShortTermInvestments
1057990000 USD
CY2012Q4 wat Waters Restoration Plan Assets
WatersRestorationPlanAssets
24827000 USD
CY2012Q4 us-gaap Foreign Currency Fair Value Hedge Asset At Fair Value
ForeignCurrencyFairValueHedgeAssetAtFairValue
1173000 USD
CY2012Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
1230222000 USD
CY2012Q4 us-gaap Foreign Currency Fair Value Hedge Liability At Fair Value
ForeignCurrencyFairValueHedgeLiabilityAtFairValue
693000 USD
CY2012Q4 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
693000 USD
CY2013Q1 us-gaap Maturity Of Foreign Currency Derivatives
MaturityOfForeignCurrencyDerivatives
The periods of these forward contracts typically range from one to three months and have varying notional amounts, which are intended to be consistent with changes in the underlying exposures.
CY2013Q1 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
130000000 USD
CY2012Q4 us-gaap Notional Amount Of Foreign Currency Fair Value Hedge Derivatives
NotionalAmountOfForeignCurrencyFairValueHedgeDerivatives
134000000 USD
CY2013Q1 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
124000 USD
CY2013Q1 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
-570000 USD
CY2013Q1 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
694000 USD
CY2012Q1 wat Cumulative Net Pre Tax Gains Losses On Forward Foreign Exchange Contracts
CumulativeNetPreTaxGainsLossesOnForwardForeignExchangeContracts
4263000 USD
CY2012Q1 us-gaap Gain Loss On Foreign Currency Fair Value Hedge Derivatives
GainLossOnForeignCurrencyFairValueHedgeDerivatives
3975000 USD
CY2012Q1 us-gaap Change In Unrealized Gain Loss On Foreign Currency Fair Value Hedging Instruments
ChangeInUnrealizedGainLossOnForeignCurrencyFairValueHedgingInstruments
288000 USD
CY2013Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
2404000 USD
CY2013Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-2101000 USD
CY2012Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
12814000 USD
CY2012Q1 us-gaap Standard Product Warranty Accrual Warranties Issued
StandardProductWarrantyAccrualWarrantiesIssued
1332000 USD
CY2012Q1 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
-1776000 USD
CY2011Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
13258000 USD
CY2013Q1 us-gaap Additional Cash And Cash Equivalent Related Text
AdditionalCashAndCashEquivalentRelatedText
The Company&#8217;s cash equivalents primarily represent highly liquid financial instruments with original maturities of 90&#160;days or less, financial instruments with longer maturities are classified as investments.
CY2013Q1 wat Cash Equivalents And Short Term Investments Amortized Cost Basis
CashEquivalentsAndShortTermInvestmentsAmortizedCostBasis
1225605000 USD
CY2013Q1 wat Cash Equivalents And Short Term Investments Gross Unrealized Losses
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedLosses
-1700000 USD
CY2013Q1 wat Cash Equivalents And Short Term Investments Gross Unrealized Gains
CashEquivalentsAndShortTermInvestmentsGrossUnrealizedGains
61000 USD
CY2013Q1 wat Cash Equivalents And Short Term Investments Fair Value
CashEquivalentsAndShortTermInvestmentsFairValue
1223966000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Next Twelve Months Range Minimum
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonthsRangeMinimum
40000000 USD
CY2013Q1 wat Cash Equivalents And Short Term Investments Debt Maturities Next Rolling Twelve Months Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesNextRollingTwelveMonthsFairValue
1112706000 USD
CY2013Q1 wat Cash Equivalents And Short Term Investments Debt Maturities Rolling Year Two Through Five Fair Value
CashEquivalentsAndShortTermInvestmentsDebtMaturitiesRollingYearTwoThroughFiveFairValue
45400000 USD
CY2013Q1 wat Debt Securities
DebtSecurities
1158106000 USD
CY2013Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73974000 USD
CY2013Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
17440000 USD
CY2013Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
144469000 USD
CY2012Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
73280000 USD
CY2012Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
16133000 USD
CY2012Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
140152000 USD
CY2013Q1 wat Intangible Assets Gross
IntangibleAssetsGross
494404000 USD
CY2012Q4 wat Intangible Assets Gross
IntangibleAssetsGross
495740000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
279411000 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
275595000 USD
CY2013Q1 us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
8 pure
CY2012 us-gaap Finite Lived Intangible Assets Average Useful Life
FiniteLivedIntangibleAssetsAverageUsefulLife
7 pure
CY2013Q1 wat Intangible Assets Gross Foreign Currency Translation Adjustments
IntangibleAssetsGrossForeignCurrencyTranslationAdjustments
-11000000 USD
CY2013Q1 us-gaap Goodwill Translation And Purchase Accounting Adjustments
GoodwillTranslationAndPurchaseAccountingAdjustments
-2000000 USD
CY2013Q1 wat Intangible Assets Accumulated Amortization Foreign Currency Translation Adjustments
IntangibleAssetsAccumulatedAmortizationForeignCurrencyTranslationAdjustments
-6000000 USD
CY2013Q1 us-gaap Significant Change In Unrecognized Tax Benefits Is Reasonably Possible Amount Of Unrecorded Benefit
SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit
-8000000 USD
CY2013Q1 wat Percentage Point Change In Effective Tax Rate
PercentagePointChangeInEffectiveTaxRate
-32.9 pure
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Next Twelve Months Range Maximum
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonthsRangeMaximum
45000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Two Range Minimum
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwoRangeMinimum
40000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Two Range Maximum
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwoRangeMaximum
45000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Three Range Minimum
FiniteLivedIntangibleAssetsAmortizationExpenseYearThreeRangeMinimum
40000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Three Range Maximum
FiniteLivedIntangibleAssetsAmortizationExpenseYearThreeRangeMaximum
45000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Four Range Minimum
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourRangeMinimum
40000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Four Range Maximum
FiniteLivedIntangibleAssetsAmortizationExpenseYearFourRangeMaximum
45000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Five Range Minimum
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveRangeMinimum
40000000 USD
CY2013Q1 wat Finite Lived Intangible Assets Amortization Expense Year Five Range Maximum
FiniteLivedIntangibleAssetsAmortizationExpenseYearFiveRangeMaximum
45000000 USD
CY2013Q1 wat Debt
Debt
1233232000 USD
CY2012Q4 wat Debt
Debt
1177781000 USD
CY2012Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
64390000 USD
CY2011Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
73199000 USD
CY2013Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
33074000 USD
CY2012Q1 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
72677000 USD
CY2013Q1 wat Change In Other Uncertain Tax Benefits
ChangeInOtherUncertainTaxBenefits
-805000 USD
CY2012Q1 wat Change In Other Uncertain Tax Benefits
ChangeInOtherUncertainTaxBenefits
-522000 USD
CY2013Q1 us-gaap Income Tax Reconciliation Tax Credits Research
IncomeTaxReconciliationTaxCreditsResearch
3000000 USD
CY2013Q1 us-gaap Unrecognized Tax Benefits Decreases Resulting From Settlements With Taxing Authorities
UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities
30511000 USD
CY2013Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7431000 USD
CY2012Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
7267000 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
32000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
5 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
32000 shares
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedTerm
6 pure
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Payments
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendPayments
0 USD
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.010 pure
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.260 pure
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.380 pure
CY2013Q1 wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
88.71
CY2012Q1 wat Weighted Average Exercise Price Of Options Granted
WeightedAverageExercisePriceOfOptionsGranted
75.94
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
22.03
CY2012Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
28.68
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4809000 shares
CY2013Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-138000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
-6000 shares
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4697000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
63.34
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
68.61
CY2013Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
64.00
CY2013Q1 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
32.12
CY2013Q1 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
88.71
CY2012Q4 wat Exercise Price Range Of Options Outstanding Lower Range Limit
ExercisePriceRangeOfOptionsOutstandingLowerRangeLimit
23.19
CY2012Q4 wat Exercise Price Range Of Options Outstanding Upper Range Limit
ExercisePriceRangeOfOptionsOutstandingUpperRangeLimit
87.06
CY2013Q1 wat Exercise Price Range Of Options Exercised Lower Range Limit
ExercisePriceRangeOfOptionsExercisedLowerRangeLimit
23.19
CY2013Q1 wat Exercise Price Range Of Options Exercised Upper Range Limit
ExercisePriceRangeOfOptionsExercisedUpperRangeLimit
79.15
CY2013Q1 wat Exercise Price Range Of Options Canceled Lower Range Limit
ExercisePriceRangeOfOptionsCanceledLowerRangeLimit
36.25
CY2013Q1 wat Exercise Price Range Of Options Canceled Upper Range Limit
ExercisePriceRangeOfOptionsCanceledUpperRangeLimit
72.06
CY2013Q1 wat Weighted Average Exercise Price Of Options Exercised
WeightedAverageExercisePriceOfOptionsExercised
46.53
CY2013Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1166000 shares
CY2013Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares
CY2012Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000 shares
CY2012Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1277000 shares
CY2013Q1 wat Estimated Total Employer Contributions To Defined Benefit Plans In Current Fiscal Year Lower Range
EstimatedTotalEmployerContributionsToDefinedBenefitPlansInCurrentFiscalYearLowerRange
8000000 USD
CY2013Q1 wat Estimated Total Employer Contributions To Defined Benefit Plans In Current Fiscal Year Higher Range
EstimatedTotalEmployerContributionsToDefinedBenefitPlansInCurrentFiscalYearHigherRange
10000000 USD

Files In Submission

Name View Source Status
0001193125-13-198015-index-headers.html Edgar Link pending
0001193125-13-198015-index.html Edgar Link pending
0001193125-13-198015.txt Edgar Link pending
0001193125-13-198015-xbrl.zip Edgar Link pending
d531339d10q.htm Edgar Link pending
d531339dex311.htm Edgar Link pending
d531339dex312.htm Edgar Link pending
d531339dex321.htm Edgar Link pending
d531339dex322.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
wat-20130330.xml Edgar Link completed
wat-20130330.xsd Edgar Link pending
wat-20130330_cal.xml Edgar Link unprocessable
wat-20130330_def.xml Edgar Link unprocessable
wat-20130330_lab.xml Edgar Link unprocessable
wat-20130330_pre.xml Edgar Link unprocessable